Wuppertal, Germany

Claudia Chiocchini

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Thermo Fisher Scientific Geneart Gmbh. Active years: 2026.

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Claudia Chiocchini: Innovator in Nucleic Acid and Protein Production

Introduction

Claudia Chiocchini is a prominent inventor based in Wuppertal, Germany. She has made significant contributions to the field of biotechnology, particularly in the production of nucleic acids and proteins. Her innovative work has led to the development of valuable technologies that enhance research and applications in molecular biology.

Latest Patents

Claudia holds a patent titled "Devices and Methods for Producing Nucleic Acids and Proteins." This patent represents her commitment to advancing scientific knowledge and improving methodologies in the biotechnology sector. She has 1 patent to her name, showcasing her inventive capabilities.

Career Highlights

Throughout her career, Claudia has worked with notable companies in the biotechnology industry. She has been associated with Thermo Fisher Scientific Geneart GmbH and Pierce Biotechnology, Inc. These experiences have allowed her to collaborate with leading experts and contribute to groundbreaking projects.

Collaborations

Claudia has worked alongside talented individuals such as Axel Trefzer and Phillip Kuhn. Their collaborative efforts have furthered advancements in their respective fields and fostered innovation in biotechnology.

Conclusion

Claudia Chiocchini is a remarkable inventor whose work in nucleic acid and protein production has made a lasting impact on the biotechnology industry. Her contributions continue to inspire future innovations and advancements in scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…